Načítá se...
Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients
In the era of immunotherapies there is an urgent need to implement the use of circulating biomarkers in clinical practice to facilitate personalized therapy and to predict treatment response. We conducted a prospective study to evaluate the usefulness of circulating exosomal-PD-L1 in melanoma patien...
Uloženo v:
| Vydáno v: | J Extracell Vesicles |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6968537/ https://ncbi.nlm.nih.gov/pubmed/32002173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20013078.2019.1710899 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|